The purpose of this study is to assess the efficacy of pelvic floor muscle training (PFMT) on urinary incontinence reports in obese women undergoing a low calorie diet prior to bariatric surgery for obesity. The study will also assess and compare rates of adherence to treatments, pelvic floor muscle function and women´s self perception of their PFM function, and satisfaction with treatment.
According to the World Health Organization (WHO), the adult overweight rate in 2014 reached 20%, with the highest prevalence among women. In addition to metabolic diseases, obesity can cause musculoskeletal disorders, including pelvic floor muscle (PFM) disorders and urinary incontinence (UI) is the most prevalent one. Conservative intervention can be medication, lifestyle changes, but pelvic floor muscle training (PFMT) is considered the first-line conservative therapy for urinary incontinence in women and it is effective when delivered both individually or in group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
20
4 sets of 10 maximal perceived voluntary pelvic floor contractions sustained for 6 seconds, followed by 5 voluntary pelvic floor muscle contractions. The supervised 4 sets will be performed in 2 different positions (sitting and standing).
Pauliana Carolina de Souza Mendes
Franca, São Paulo, Brazil
RECRUITINGSelf report of urinary incontinence by women
Self report of urinary incontinence measured using question 3 of the ICIQ-SF. Women will be considered incontinent if they choose option 1,2,3,4,5 of question 3. Women will be considered continent if they choose option 0 of question 3.
Time frame: Women will be evaluated at baseline
Severity and impact of Urinary incontinence in women´s quality of life
the severity and impact of Urinary incontinence in women´s quality of life will be measured using the ICIQ-SF score
Time frame: Women will be evaluated at baseline
Participants' adherence to the PFMT protocol
Will be assessed using an exercise diary and the complier average causal effects (CACE) method
Time frame: Women will be evaluated at baseline and right after 12 weeks
PFM function
the modified Oxford grading scale- MOS (digital vaginal palpation)
Time frame: Women will be evaluated at baseline
participants self-perception of their PFM function
women´s self-perception of their PFM function according to the MOS categories
Time frame: Women will be evaluated at baseline
Satisfaction with treatment
Analogic visual scale where 0 represents no satisfaction with treatment and 10 the maximum satisfaction
Time frame: only after 12 weeks from the baseline assessment
Subjective satisfaction with treatment
Women will answer the following questions: are you satisfied with the treatment you received for UI? would you do this treatment again ? would you recomend this treatment ? to other people, would you chase another treatment ?
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: only after 12 weeks from the baseline assessment
Identification of barriers for the treatment
Women will answer the following questions: Do identifie any barrier or difficulty to adhere to the treatment you received for urinary incontinence?
Time frame: only after 12 weeks from the baseline assessment